June 21 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- CYNATA REPORTS POSITIVE 28-DAY DATA FROM COHORT B OF PHASE 1 TRIAL OF CYP-001 IN GVHD
- CYNATA THERAPEUTICS - NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS OR SAFETY CONCERNS HAVE BEEN IDENTIFIED IN PHASE 1 CLINICAL TRIAL OF CYP-001
To read reuters' full disclaimer click here